AU2002350832A1 - Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension - Google Patents
Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertensionInfo
- Publication number
- AU2002350832A1 AU2002350832A1 AU2002350832A AU2002350832A AU2002350832A1 AU 2002350832 A1 AU2002350832 A1 AU 2002350832A1 AU 2002350832 A AU2002350832 A AU 2002350832A AU 2002350832 A AU2002350832 A AU 2002350832A AU 2002350832 A1 AU2002350832 A1 AU 2002350832A1
- Authority
- AU
- Australia
- Prior art keywords
- irbesartan
- medicaments
- preparation
- prevent
- pulmonary hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002947 C09CA04 - Irbesartan Substances 0.000 title 1
- YCPOHTHPUREGFM-UHFFFAOYSA-N Irbesartan Chemical compound O=C1N(CC=2C=CC(=CC=2)C=2C(=CC=CC=2)C=2[N]N=NN=2)C(CCCC)=NC21CCCC2 YCPOHTHPUREGFM-UHFFFAOYSA-N 0.000 title 1
- 208000002815 Pulmonary Hypertension Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229960002198 irbesartan Drugs 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR01/13936 | 2001-10-26 | ||
| FR0113936A FR2831446B1 (en) | 2001-10-26 | 2001-10-26 | USE OF IRBESARTAN FOR THE PREPARATION OF MEDICINES USEFUL FOR THE PREVENTION OR TREATMENT OF PULMONARY HYPERTENSION |
| PCT/FR2002/003439 WO2003035062A1 (en) | 2001-10-26 | 2002-10-09 | Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002350832A1 true AU2002350832A1 (en) | 2003-07-03 |
| AU2002350832B2 AU2002350832B2 (en) | 2006-11-30 |
Family
ID=8868812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002350832A Ceased AU2002350832B2 (en) | 2001-10-26 | 2002-10-09 | Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20040242567A1 (en) |
| EP (1) | EP1441723B1 (en) |
| JP (1) | JP4542777B2 (en) |
| CN (1) | CN100418526C (en) |
| AT (1) | ATE361071T1 (en) |
| AU (1) | AU2002350832B2 (en) |
| BR (1) | BR0213479A (en) |
| CA (1) | CA2461625C (en) |
| CY (1) | CY1106746T1 (en) |
| DE (1) | DE60219940T2 (en) |
| DK (1) | DK1441723T3 (en) |
| EA (1) | EA007952B1 (en) |
| ES (1) | ES2286304T3 (en) |
| FR (1) | FR2831446B1 (en) |
| HU (1) | HUP0401633A3 (en) |
| IL (2) | IL161116A0 (en) |
| IS (1) | IS2849B (en) |
| MX (1) | MXPA04003910A (en) |
| NO (1) | NO332313B1 (en) |
| NZ (1) | NZ532130A (en) |
| PL (1) | PL209263B1 (en) |
| PT (1) | PT1441723E (en) |
| WO (1) | WO2003035062A1 (en) |
| ZA (1) | ZA200402696B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| US7811606B2 (en) | 2003-04-16 | 2010-10-12 | Dey, L.P. | Nasal pharmaceutical formulations and methods of using the same |
| US9808471B2 (en) | 2003-04-16 | 2017-11-07 | Mylan Specialty Lp | Nasal pharmaceutical formulations and methods of using the same |
| US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
| TR200301553A1 (en) * | 2003-09-18 | 2005-10-21 | Nobel �La� Sanay�� Ve T�Caret A.�. | New oral pharmaceutical formulations containing irbesartan active ingredient |
| EP1750862B1 (en) | 2004-06-04 | 2011-01-05 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical composition containing irbesartan |
| WO2006067601A1 (en) * | 2004-12-23 | 2006-06-29 | Ranbaxy Laboratories Limited | Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation |
| CN100367959C (en) * | 2006-08-29 | 2008-02-13 | 陈俊云 | Medicine contg. irbesartan |
| GB0617171D0 (en) * | 2006-08-31 | 2006-10-11 | Generics Uk Ltd | Novel compositions and methods |
| EP4313024A1 (en) * | 2021-03-23 | 2024-02-07 | Dimerix Bioscience Pty Ltd | Treatment of inflammatory diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
| TW201738B (en) * | 1990-03-20 | 1993-03-11 | Sanofi Co | |
| US5270317A (en) * | 1990-03-20 | 1993-12-14 | Elf Sanofi | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| RU2086544C1 (en) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Benzenesulfonamide derivatives of pyrimidine or their salts, pharmaceutical composition for treatment of diseases associated with endothelin activity |
| US5292741A (en) * | 1992-08-18 | 1994-03-08 | Merck & Co., Inc. | Macrocycles incorporating quinazolinones |
| US20020068740A1 (en) | 1999-12-07 | 2002-06-06 | Mylari Banavara L. | Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
-
2001
- 2001-10-26 FR FR0113936A patent/FR2831446B1/en not_active Expired - Fee Related
-
2002
- 2002-10-09 IL IL16111602A patent/IL161116A0/en unknown
- 2002-10-09 EA EA200400438A patent/EA007952B1/en not_active IP Right Cessation
- 2002-10-09 AT AT02785535T patent/ATE361071T1/en active
- 2002-10-09 AU AU2002350832A patent/AU2002350832B2/en not_active Ceased
- 2002-10-09 HU HU0401633A patent/HUP0401633A3/en unknown
- 2002-10-09 CN CNB028213041A patent/CN100418526C/en not_active Expired - Fee Related
- 2002-10-09 MX MXPA04003910A patent/MXPA04003910A/en active IP Right Grant
- 2002-10-09 BR BR0213479-9A patent/BR0213479A/en not_active Application Discontinuation
- 2002-10-09 JP JP2003537629A patent/JP4542777B2/en not_active Expired - Fee Related
- 2002-10-09 PL PL368737A patent/PL209263B1/en unknown
- 2002-10-09 CA CA2461625A patent/CA2461625C/en not_active Expired - Fee Related
- 2002-10-09 PT PT02785535T patent/PT1441723E/en unknown
- 2002-10-09 ES ES02785535T patent/ES2286304T3/en not_active Expired - Lifetime
- 2002-10-09 DK DK02785535T patent/DK1441723T3/en active
- 2002-10-09 US US10/492,804 patent/US20040242567A1/en not_active Abandoned
- 2002-10-09 WO PCT/FR2002/003439 patent/WO2003035062A1/en active IP Right Grant
- 2002-10-09 NZ NZ532130A patent/NZ532130A/en not_active IP Right Cessation
- 2002-10-09 DE DE60219940T patent/DE60219940T2/en not_active Expired - Lifetime
- 2002-10-09 EP EP02785535A patent/EP1441723B1/en not_active Expired - Lifetime
-
2004
- 2004-03-25 IL IL161116A patent/IL161116A/en not_active IP Right Cessation
- 2004-03-29 IS IS7200A patent/IS2849B/en unknown
- 2004-04-06 ZA ZA2004/02696A patent/ZA200402696B/en unknown
- 2004-04-23 NO NO20041732A patent/NO332313B1/en not_active IP Right Cessation
-
2007
- 2007-07-19 CY CY20071100964T patent/CY1106746T1/en unknown
-
2009
- 2009-06-03 US US12/477,562 patent/US8088827B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003048081A3 (en) | Glycinamides as factor xa inhibitors | |
| AU2002305205A1 (en) | 9-deazaguanine derivatives as inhibitors of gsk-3 | |
| HUP0401514A3 (en) | Pharmaceutical compositions for the treatment of asthma | |
| AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
| WO2002036562A3 (en) | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands | |
| AU2003289888A1 (en) | Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders | |
| IL158289A (en) | Mercaptoacetylamide derivatives, a process for their preparation and their use as medicaments for the treatment of hypertension and chf | |
| AU2003219100A1 (en) | Pyrazolopyridazine derivatives, process for preparation and use for the inhibition of gsk-3 | |
| AU2002240359A1 (en) | Pharmaceutical composition for the treatment of alopecia | |
| AU2003258145A1 (en) | Substituted phenylindoles for the treatment of hiv | |
| AU2002233928A1 (en) | Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases | |
| AU2003290059A1 (en) | Use of cd137 antagonists for the treatment of tumors | |
| AU2002350832A1 (en) | Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension | |
| WO2003037863A3 (en) | Substituted indoles, method for production and use thereof for the inhibition of pain | |
| HUP0401633A3 (en) | Use of irbesartan for the preparation of pharmaceutical compositions that are used to prevent or treat pulmonary hypertension | |
| AU2002362505A1 (en) | Compression sleeve for treatment of the extremities | |
| AU2003260983A1 (en) | Processes for the preparation of s-(-)-amlodipine | |
| AU2002249947A1 (en) | Inhibition of protein-phosphatases for the treatment of heart failure | |
| AU2003220026A1 (en) | Methods and compositions for the treatment of ischemia | |
| AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
| AU2003251362A1 (en) | Compositions formed from the reduction of lanolin | |
| AU2002221566A1 (en) | Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders | |
| SI1441723T1 (en) | Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension | |
| AU2003240174A1 (en) | Compositions for the treatment of edematous-firbrosclerotic panniculopathy | |
| WO2005105799A8 (en) | Dialkoxy-imidazopyridines derivatives |